-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Surrozen, Inc. (NASDAQ:SRZN) Short Interest Down 18.7% in January
Surrozen, Inc. (NASDAQ:SRZN) Short Interest Down 18.7% in January
Surrozen, Inc. (NASDAQ:SRZN – Get Rating) was the recipient of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 227,300 shares, a decrease of 18.7% from the December 31st total of 279,700 shares. Based on an average trading volume of 812,000 shares, the short-interest ratio is currently 0.3 days. Currently, 1.2% of the shares of the stock are sold short.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the stock. Bank of Montreal Can purchased a new position in shares of Surrozen during the 1st quarter worth about $377,000. FMR LLC purchased a new position in shares of Surrozen during the 2nd quarter worth about $744,000. Vanguard Group Inc. lifted its holdings in shares of Surrozen by 3.2% during the 3rd quarter. Vanguard Group Inc. now owns 487,278 shares of the company's stock worth $984,000 after acquiring an additional 15,299 shares during the period. Finally, Board of Trustees of The Leland Stanford Junior University lifted its holdings in shares of Surrozen by 3,102.9% during the 3rd quarter. Board of Trustees of The Leland Stanford Junior University now owns 781,960 shares of the company's stock worth $1,580,000 after acquiring an additional 757,546 shares during the period. 62.13% of the stock is currently owned by hedge funds and other institutional investors.
Get Surrozen alerts:Analyst Ratings Changes
A number of brokerages recently commented on SRZN. Bank of America cut shares of Surrozen from a "neutral" rating to an "underperform" rating in a research note on Wednesday, November 16th. Guggenheim cut shares of Surrozen from a "buy" rating to a "neutral" rating in a research note on Friday, November 18th. Finally, JPMorgan Chase & Co. cut shares of Surrozen from a "neutral" rating to an "underweight" rating in a research note on Tuesday, November 29th.
Surrozen Price Performance
Shares of Surrozen stock remained flat at $0.72 during mid-day trading on Friday. 409,438 shares of the company's stock traded hands, compared to its average volume of 753,427. Surrozen has a one year low of $0.34 and a one year high of $3.97. The company has a market cap of $25.29 million, a PE ratio of -0.53 and a beta of -0.24. The stock has a fifty day moving average of $0.60 and a 200-day moving average of $1.83.Surrozen (NASDAQ:SRZN – Get Rating) last released its quarterly earnings results on Monday, November 14th. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.05. As a group, equities research analysts expect that Surrozen will post -1.46 earnings per share for the current year.
Surrozen Company Profile
(Get Rating)
Surrozen, Inc, a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.
Read More
- Get a free copy of the StockNews.com research report on Surrozen (SRZN)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
Receive News & Ratings for Surrozen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surrozen and related companies with MarketBeat.com's FREE daily email newsletter.
Surrozen,Inc.(纳斯达克:SRZN-GET评级)是空头股数在1月份大幅下降的接受者。截至1月15日,空头股数共有22.73万股,较12月31日的27.97万股减少18.7%。以81.2万股的平均成交量计算,目前短息比为0.3天。目前,该股1.2%的股份被卖空。
机构资金流入和流出
大型投资者最近调整了对该股的持有量。蒙特利尔银行可以在第一季度购买Surrozen的新头寸,价值约37.7万美元。FMR LLC在第二季度购买了Surrozen的新头寸,价值约744,000美元。先锋集团(Vanguard Group Inc.)在第三季度增持了3.2%的Surrozen股票。先锋集团在此期间增持了15,299股,目前持有487,278股该公司股票,价值98.4,000美元。最后,利兰·斯坦福初级大学董事会在第三季度增持了3102.9%的Surrozen股票。利兰·斯坦福初级大学董事会在此期间额外收购了757,546股,目前拥有781,960股该公司股票,价值1,580,000美元。62.13%的股票目前由对冲基金和其他机构投资者持有。
到达苏罗森警报:分析师评级发生变化
多家券商近日对SRZN发表评论。11月16日星期三,美国银行在一份研究报告中将苏罗岑的股票评级从“中性”下调至“表现不佳”。在11月18日星期五的一份研究报告中,古根海姆将苏罗岑的股票评级从“买入”下调至“中性”。最后,摩根大通公司在11月29日星期二的一份研究报告中将苏罗岑的股票评级从中性下调至减持。
超高性价比
在周五午盘交易中,Surrozen的股价持平于0.72美元。该公司股票成交量为409,438股,而其平均成交量为753,427股。Surrozen的一年低点为0.34美元,一年高位为3.97美元。该公司市值为2529万美元,市盈率为-0.53,贝塔系数为-0.24。该股的50日移动均线为0.60美元,200日移动均线为1.83美元。Surrozen(纳斯达克代码:SRZN-GET Rating)上一次发布季度收益报告是在11月14日(星期一)。该公司公布本季度每股收益(EPS)为0.38美元,比普遍预期的0.43美元高出0.05美元。作为一个整体,股票研究分析师预计苏罗岑本年度的每股收益将达到1.46美元。
苏罗森公司简介
(获取评级)
苏罗森公司是一家生物技术公司,该公司发现和开发候选药物,以选择性地调节Wnt途径,以进行组织修复和再生。它正在开发组织特异性抗体,并将其应用于各种疾病领域,包括肠道、肝脏、视网膜、角膜、肺、肾脏、耳蜗病、皮肤、胰腺和中枢神经系统疾病。
阅读更多内容
- 免费获取StockNews.com关于Surrozen的研究报告(SRZN)
- 市场回顾周-1/23-1/27
- 为什么Lucid在一天内飙升了近100%
- 利用这些铁路股票实现增长和收入
- ASML预计今年芯片需求回升,提振销售观点
- KLA公司:在动荡不安的半市场中站稳脚跟
接受《Surrozen Daily》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Surrozen和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧